Medtech featured in April’s Australasian Biotechnology journal


The Australian medtech sector takes centre stage in the April edition of Australasian Biotechnology, AusBiotech’s official journal, in anticipation of the upcoming AusMedtech 2019 conference.

Commentary is provided from a diverse range of contributors, with highlights of this edition including profiles on winners of the most recent AusBiotech and Johnson and Johnson Industry Leadership Awards; Meagan Ryan, Intellectual Property Disputes Lawyer, arguing on whether fitness watches should be regulated as medical devices; Dr Renee White, Patent Trademarks Attorney, Watermark, discussing whether patent law can keep up with the trajectory of medical AI innovation; and Dr Samih Nabulsi, Managing Director, Cook Medical, sharing three guiding principles crucial for successful collaborative partnerships. OncoRes Medical and Brandon Capital Partners highlight how they’ve taken Australian technology to the world, and received global recognition after being named joint winner of the Pitch@Palace Global 3.0 in December last year.

The April journal also contains regular features, including the AusBiotech Chair and CEO Report, and AusBioStock – an exclusive report from James Fletcher, Baillieu Holst. The journal welcomes new AusBiotech members, and holds a list of AusBiotech corporate members. AusBiotech members (located in Australia) will shortly receive a print copy of the journal in the mail.

In-depth commentary on the Australian and global medical technology sector will continue at AusMedtech 2019, being held 14-15 May in Melbourne. Registrations are still open.

The next edition of Australasian Biotechnology will be released in October. Please contact AusBiotech if you are interested in contributing, or to find out about advertising opportunities.

Australasian Biotechnology is published bi-annually in partnership with Executive Media.